Company & Sponsor Intelligence
Hôpital le Vinatier
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting4
Completed1
Countries1
Therapeutic footprint
autismdepressionintellectual_disabilityother_psychiatryschizophrenia
Indexed studies
NCT07716982Estimation of Control Before and After Treatment of a Depressive Episode With Serotonin Reuptake Inhibitors
depression · FranceNA
depression · FranceNA
NCT03254264Impact of Early Interventions on Neurocognitive Profile of Children With Autism Spectrum Disorder
autism · FranceNA
autism · FranceNA
NCT02608333Efficiency of Early Intervention for Autism Spectrum Disorder
autism · FranceNA
autism · FranceNA
NCT04025398A Computer-based Cognitive Remediation Program for Adults With Intellectual Disability
intellectual_disability · FranceNA
intellectual_disability · FranceNA
NCT02746510Validation of a Clinical Screening Grid for Syndromic Schizophrenia
schizophrenia · FranceNA
schizophrenia · FranceNA
NCT07545798Bright Light Therapy During Inpatient Cocaine Detoxification
other_psychiatry · FranceNA
other_psychiatry · FranceNA
NCT07384819Duration of Moment in Autism
autism · FranceNA
autism · FranceNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →